Assignee
FRIESS THOMAS
DE·1 granted patent·13 pending applications·13 citations·filing 2007–2012
Top patents by PatentIndex Score
14 records- 0187US9090700B2Tumor therapy with an antibody for vascular endothelial growth factor and an antibody for human epithelial growth factor receptor type 2FRIESS THOMAS·Filed 2010·Granted Jul 28, 2015·13 cites·9 claims
- 0262US2011243931A1Combination therapy with type i and type ii anti-cd20 antibodiesFRIESS THOMAS·Filed 2008·Application pending·0 cites
- 0362US2009060913A1Combination therapy with type i and type ii anti-cd20 antibodiesFRIESS THOMAS·Filed 2008·Application pending·0 cites
- 0462US2009098118A1Combination therapy of a type ii anti-cd20 antibody with an anti-bcl-2 active agentFRIESS THOMAS·Filed 2008·Application pending·0 cites
- 0560US2008050385A1Tumor therapy with an anti-vegf antibodyFRIESS THOMAS·Filed 2007·Application pending·0 cites
- 0657US2007224203A1Tumor therapy with an antibody for vascular endothelial growth factor and an antibody for human epithelial growth factor receptor type 2FRIESS THOMAS·Filed 2007·Application pending·0 cites
- 0757US2013183292A1Tumor therapy with an anti-vegf antibodyFRIESS THOMAS·Filed 2012·Application pending·0 cites
- 0855US2012276085A1Combination therapy of a type ii anti-cd20 antibody with an anti-bcl-2 active agentFRIESS THOMAS·Filed 2012·Application pending·0 cites
- 0955US2013195846A1Combination therapy with type i and type ii anti-cd20 antibodiesFRIESS THOMAS·Filed 2012·Application pending·0 cites
- 1054US2011287006A1Combination therapy of a type ii anti-cd20 antibody with an anti-bcl-2 active agentFRIESS THOMAS·Filed 2011·Application pending·0 cites
- 1154US2012134990A1Combination therapy with type i and type ii anti-cd20 antibodiesFRIESS THOMAS·Filed 2012·Application pending·0 cites
- 1251US2010285010A1Tumor therapy with an anti-vegf antibodyFRIESS THOMAS·Filed 2010·Application pending·0 cites
- 1344US2008102069A1Tumor therapy with a combination of anti-her2 antibodiesFRIESS THOMAS·Filed 2007·Application pending·0 cites
- 1439US2010247533A1TREATMENT WITH A HUMANIZED ANTI-EGFR IgG1 ANTIBODY AND IRINOTECANFRIESS THOMAS·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when FRIESS THOMAS files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →